Guru Ownership Trend
Guru Analysis for Keros Therapeutics, Inc. (KROS)
Keros Therapeutics, Inc. (KROS), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $15.09 M.
Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $3.63 M net inflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 138.1%. Conversely, Steven Cohen reduced exposure by 90.5%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Keros Therapeutics, Inc. (KROS)
Major holders include Cliff Asness ($10.36 M), Renaissance Technologies (RenTech) ($3.84 M), Steven Cohen ($111,205). According to the latest reported data, 3 tracked investment managers collectively hold approximately 1.34 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $3.63 M, with 1 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited KROS. The total reported sell value was $2.37 M.
Yes, 0 managers opened new positions in KROS, and 1 increased their existing holdings. The total reported buy value was $6.01 M.